Age-Related Macular Degeneration: 68-Market Analysis and Sales Forecast
Description
Age-Related Macular Degeneration: 68-Market Analysis and Sales Forecast
Summary
This report covers the 68 geographical markets and provides an Excel-based forecast model for the Age-Related Macular Degeneration (AMD) market.
Across the 68 markets, sales in the AMD market were $8.9 billion in 2024, growing to $24.1 billion in 2034.
The seven major markets (US, France, Germany, Italy, Spain, UK, and Japan) represent approximately 87.0% and 85.2% in 68-market sales in 2024 and 2034, respectively.
Scope
Summary
This report covers the 68 geographical markets and provides an Excel-based forecast model for the Age-Related Macular Degeneration (AMD) market.
Across the 68 markets, sales in the AMD market were $8.9 billion in 2024, growing to $24.1 billion in 2034.
The seven major markets (US, France, Germany, Italy, Spain, UK, and Japan) represent approximately 87.0% and 85.2% in 68-market sales in 2024 and 2034, respectively.
Scope
- This publication is an expanded version of the Excel model containing the patient-based forecast sales for AMD, covered in GlobalData’s report “Age-Related Macular Degeneration: Seven-Market Analysis and Sales Forecast”, published in December 2025. In addition to patient based forecast sales data for the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan), this report contains sales forecast extrapolations for an additional 60 geographical markets (60M), totaling 68 markets (68M).
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the 68M AMD therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the 68M AMD therapeutics market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Table of Contents
20 Pages
- 1 Executive Summary
- 1.1 Overview
- 1.2 68M summary statistics
- 1.3 Key 7MM events driving the 68M forecast extrapolation
- 2 Appendix
- 2.1 Abbreviations
- 2.2 Methodology
- 2.2.1 Patient-based forecast methodology
- 2.2.2 68M forecast extrapolation methodology
- 2.3 Primary research - key opinion leaders interviewed for this report
- 2.3.1 Key opinion leaders
- 2.4 Primary research - prescriber survey
- 2.5 About the authors
- 2.5.1 Managing Analyst
- 2.5.2 Therapy area directors
- 2.5.3 Epidemiologist
- 2.5.4 Epidemiology reviewers
- 2.5.5 Vice President of Disease Intelligence and Epidemiology
- 2.5.6 Global Head and EVP of Healthcare Operations and Strategy
- About GlobalData
- Contact Us
- List of Tables
- Table 1: AMD market size across the 68M - 7MM versus 61M
- Table 2: AMD market size across the 68M - by geographical region
- Table 3: AMD key events occurring in the 7MM driving forecast trajectory in the 68M
- Table 4: High-prescribing physicians (non-KOLs) surveyed, by country
- List of Figures
- Figure 1: AMD market size across the 68M - 7MM versus 61M
- Figure 2: AMD market size across the 68M - by geographical region
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


